Have your own idea? Try our Stock Screener
Israeli (TA) Pharma Industry Analysis
UpdatedFeb 21, 2026
DataAggregated Company Financials
Companies6
- 7D-0.2%
- 3M-12.5%
- 1Y-39.8%
- YTD0.2%
The Pharma is pretty flat in the last 7 days, but Nextgen Biomed has stood out, gaining 7.0%. As for the longer term, the industry has declined 40% in the last year.
Industry Valuation and Performance
Has the Israeli Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 21 Feb 2026 | ₪461.2m | ₪706.6m | -₪88,140,918.40 | 6.7x | -5.2x | 0.7x |
| Mon, 19 Jan 2026 | ₪454.5m | ₪706.6m | -₪88,226,094.60 | 6.1x | -5.2x | 0.6x |
| Wed, 17 Dec 2025 | ₪532.0m | ₪706.6m | -₪93,391,503.70 | 5.9x | -5.7x | 0.8x |
| Fri, 14 Nov 2025 | ₪572.4m | ₪720.3m | -₪92,527,642.00 | 6.6x | -6.2x | 0.8x |
| Sun, 12 Oct 2025 | ₪619.2m | ₪720.3m | -₪92,730,516.70 | 6.9x | -6.7x | 0.9x |
| Tue, 09 Sep 2025 | ₪567.8m | ₪716.6m | -₪84,367,392.10 | 6.8x | -6.7x | 0.8x |
| Thu, 07 Aug 2025 | ₪555.8m | ₪716.7m | -₪71,875,729.90 | 29.3x | -7.7x | 0.8x |
| Sat, 05 Jul 2025 | ₪573.1m | ₪716.7m | -₪71,526,657.10 | 31.2x | -8x | 0.8x |
| Mon, 02 Jun 2025 | ₪594.6m | ₪730.2m | -₪68,583,747.80 | 15.8x | -8.7x | 0.8x |
| Wed, 30 Apr 2025 | ₪599.2m | ₪766.6m | -₪80,198,940.00 | 15.3x | -7.5x | 0.8x |
| Fri, 28 Mar 2025 | ₪600.1m | ₪832.5m | -₪145,809,700.00 | 12.8x | -4.1x | 0.7x |
| Sun, 23 Feb 2025 | ₪690.6m | ₪828.6m | -₪180,219,365.60 | 22x | -3.8x | 0.8x |
| Tue, 21 Jan 2025 | ₪681.4m | ₪828.6m | -₪180,185,557.40 | 20.8x | -3.8x | 0.8x |
| Thu, 19 Dec 2024 | ₪636.6m | ₪828.6m | -₪180,465,349.40 | 21x | -3.5x | 0.8x |
| Sat, 16 Nov 2024 | ₪590.1m | ₪816.0m | -₪200,862,110.50 | 24.1x | -2.9x | 0.7x |
| Mon, 14 Oct 2024 | ₪654.3m | ₪808.7m | -₪205,828,142.90 | 23.8x | -3.2x | 0.8x |
| Wed, 11 Sep 2024 | ₪712.9m | ₪810.4m | -₪244,606,431.30 | 23.6x | -2.9x | 0.9x |
| Fri, 09 Aug 2024 | ₪643.9m | ₪901.7m | -₪263,686,302.40 | n/a | -2.4x | 0.7x |
| Sun, 07 Jul 2024 | ₪695.9m | ₪901.7m | -₪261,995,666.00 | n/a | -2.7x | 0.8x |
| Tue, 04 Jun 2024 | ₪835.7m | ₪886.2m | -₪255,610,813.20 | n/a | -3.3x | 0.9x |
| Thu, 02 May 2024 | ₪863.4m | ₪956.4m | -₪180,534,652.00 | 25.1x | -4.8x | 0.9x |
| Sat, 30 Mar 2024 | ₪777.1m | ₪972.3m | -₪208,882,296.00 | 20.8x | -3.7x | 0.8x |
| Mon, 26 Feb 2024 | ₪653.3m | ₪972.3m | -₪212,022,859.30 | 14.7x | -3.1x | 0.7x |
| Wed, 24 Jan 2024 | ₪561.9m | ₪972.3m | -₪214,708,392.00 | 11x | -2.6x | 0.6x |
| Fri, 22 Dec 2023 | ₪578.6m | ₪972.3m | -₪211,885,950.00 | 10.3x | -2.7x | 0.6x |
| Sun, 19 Nov 2023 | ₪579.6m | ₪958.8m | -₪207,826,763.00 | 10x | -2.8x | 0.6x |
| Tue, 17 Oct 2023 | ₪642.7m | ₪958.8m | -₪213,742,191.00 | 11.4x | -3x | 0.7x |
| Thu, 14 Sep 2023 | ₪673.2m | ₪958.8m | -₪210,107,862.00 | 13.4x | -3.2x | 0.7x |
| Sat, 12 Aug 2023 | ₪655.5m | ₪918.8m | -₪127,258,837.00 | 8.4x | -5.2x | 0.7x |
| Mon, 10 Jul 2023 | ₪655.3m | ₪918.8m | -₪126,423,431.00 | 8.4x | -5.2x | 0.7x |
| Wed, 07 Jun 2023 | ₪756.2m | ₪912.7m | -₪126,824,636.00 | 10.4x | -6x | 0.8x |
| Fri, 05 May 2023 | ₪809.8m | ₪887.2m | -₪121,794,034.00 | 8x | -6.6x | 0.9x |
| Sun, 02 Apr 2023 | ₪764.0m | ₪829.2m | -₪97,816,963.00 | 10.9x | -7.8x | 0.9x |
| Tue, 28 Feb 2023 | ₪903.3m | ₪815.6m | -₪72,330,558.00 | 13.3x | -12.5x | 1.1x |
Price to Earnings Ratio
-12.5x
Current Industry PE
- Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading close to its 3-year average PS ratio of 0.77x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
- Revenues have also declined 4.7% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | 1.32% | |
| Healthcare | 0.64% | |
| Pharma | -0.20% | |
| Pharma | -0.20% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NXGN-M Nextgen Biomed | ₪0.50 | 7.0% +₪488.4k | -13.3% | PE-0.8x | |
| YBRD Y.B Urban Renewal - Residential Development | ₪7.37 | 0.4% +₪147.6k | -7.5% | PB4.7x |